These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33564444)

  • 21. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients.
    Cohen G; Rudnicki M; Schmaldienst S; Hörl WH
    Nephrol Dial Transplant; 2002 May; 17(5):879-83. PubMed ID: 11981077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erratum: A randomized cross-over study with objective quantification of the performance of an asymmetric triacetate and a polysulfone dialysis membrane using different anticoagulation strategies.
    Vanommeslaeghe F; Josipovic I; Boone M; Dhondt A; Van Biesen W; Eloot S
    Clin Kidney J; 2021 Jan; 14(1):463-464. PubMed ID: 33738098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility?
    Grooteman MP; Nube MJ; van Limbeek J; Schoorl M; van Houte AJ
    Nephrol Dial Transplant; 1996 Jun; 11(6):1073-8. PubMed ID: 8671971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute reactions to polysulfone/polyethersulfone dialysers: literature review and management.
    Boer WH; Liem Y; de Beus E; Abrahams AC
    Neth J Med; 2017 Jan; 75(1):4-13. PubMed ID: 28124665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
    Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trial use of a polymethylmethacrylate membrane for the removal of free immunoglobulin light chains in dialysis patients.
    Oshihara W; Nagao H; Megano H; Arai J; Koide M; Takada M
    NDT Plus; 2010 May; 3(Suppl 1):i3-i7. PubMed ID: 27046285
    [No Abstract]   [Full Text] [Related]  

  • 29. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.
    Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D
    Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of biomaterials as components of a reciprocating dialyser during canine dialysis.
    Davidson GW; Peppas NA; Thornhill JA; Ash SR
    Biomaterials; 1984 Jul; 5(4):227-33. PubMed ID: 6487703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical comparison of 8 h haemodialysis and 4 h haemodiafiltration, and two dialysis membranes, in a randomized cross-over trial.
    Choo SZ; Polkinghorne KR; Kerr PG
    Nephrology (Carlton); 2019 May; 24(5):542-549. PubMed ID: 29722110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis.
    Urbani A; Sirolli V; Lupisella S; Levi-Mortera S; Pavone B; Pieroni L; Amoroso L; Di Vito R; Bucci S; Bernardini S; Sacchetta P; Bonomini M
    Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s101-12. PubMed ID: 22890260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
    Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
    Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citrate regional anticoagulation in haemodialysis.
    Hocken AG; Hurst PL
    Nephron; 1987; 46(1):7-10. PubMed ID: 3600914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between dialyser type and signs and symptoms.
    Levin NW; Zasuwa G
    Nephrol Dial Transplant; 1993; 8 Suppl 2():30-9. PubMed ID: 8272250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
    François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
    BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fondaparinux as an alternative to vitamin K antagonists in haemodialysis patients.
    Speeckaert MM; Devreese KM; Vanholder RC; Dhondt A
    Nephrol Dial Transplant; 2013 Dec; 28(12):3090-5. PubMed ID: 24021678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of internal hemodiafiltration (iHDF): a diffusive-convective technique performed with internal filtration enhanced high-flux dialyzers.
    Lucchi L; Fiore GB; Guadagni G; Perrone S; Malaguti V; Caruso F; Fumero R; Albertazzi A
    Int J Artif Organs; 2004 May; 27(5):414-9. PubMed ID: 15202820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis.
    Gaze DC; Collinson PO
    Open Heart; 2014; 1(1):e000108. PubMed ID: 25332816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing dialyser clearance-from target to development.
    Tangvoraphonkchai K; Davenport A
    Pediatr Nephrol; 2017 Dec; 32(12):2225-2233. PubMed ID: 28401301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.